Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
Lux Capital
Activity from announced rounds
Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.
Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.
Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.
Sources
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 4 roles undisclosed
- New companies
- 7 First participation on record · 1 follow-on
- Funding in participating rounds
- $2.7B 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionOptimizes AI inference to reduce compute costs and response time
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
Builds AI agent harnesses for asset managers' proprietary research and data
Physical AI platform capturing real-world lab science into machine-readable data
Builds highly automated factories producing defense and aerospace systems
Operates autonomous sensing balloons and AI models for weather forecasting infrastructure
Agon develops virtual environments for defence companies and governments to train and evaluate autonomous AI systems.